UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

 UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

Shots:

  • The collaboration will merge Microsoft’s computational services, cloud and AI with UCB’s drug discovery and development capabilities
  • The companies intend to discover and develop medicines for people living with severe diseases in immunology and neurology. The collaboration follows UCB and Microsoft’s collaboration around COVID-19
  • Microsoft will provide AI technology and applied scientists to work alongside UCB’s scientist and data specialist that will allow UCB to discover new correlations and patterns critical to find new and highly individualized medicines

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: PRNewswire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post